Our previous study found that cancer cells’ energy resource and reliance varies a lot [12], here we found that CAV1 is highly involved in the glycolysis and OXPHOS-inhibition drug resistance, which partially elucidate the working mechanisms of CAV1 in gliomas. This evidence concerns the gene CAV1 and central nervous system cancer.